Circulating Extracellular Vesicle Tissue Factor Activity in Chuvash Erythrocytosis

• Published in: Blood 2020-11, Vol.136 (Supplement 1), p.36-36
• Main Authors: Shah, Binal N., Sergueev, Ivan, Sergueeva, Adelina, Miasnikova, Galina, Tuktanov, Nikolai, Zhang, Xu, Khanna, Deepika, Song, Jihyun, Mackman, Nigel, Prchal, Josef T., Gordeuk, Victor R.
• Format: Article
• Language: English
• ISSN: 0006-4971; 1528-0020
• DOI: 10.1182/blood-2020-141106

Background:Chuvash erythrocytosis (CE), an inherited autosomal recessive disease endemic to Russia’s mid-Volga River region, is caused by a germlineVHLC598T mutation (encoding VHLR200W) that alters oxygen sensing (PMID: 12415268). VHLR200W protein displays impaired degradation of hypoxia inducible transcription factor (HIF)-α subunits leading to increased HIF-1 and HIF-2 in normoxia and increased transcription of many HIF-regulated genes including erythropoietin (PMID: 14726398). CE patients have increased risk of venous and arterial thromboses, which are the major cause of morbidity and mortality (PMID:28104701). Thrombosis occurs despite lower blood pressure, body mass index and white blood cells compared to controls and is not related to the elevation in hematocrit but is increased in patients treated with phlebotomy therapy (PMID: 31289208). We have shown by microarray analysis of CE peripheral blood mononuclear cells modestly increased expression of several HIF-regulated pro-thrombotic genes at false discovery rate